Cargando…
Experimental identification of cancer driver alterations in the era of pan‐cancer genomics
Rapidly accumulating data from large‐scale cancer genomics studies have been generating important information about genes and their somatic alterations underlying cell transformation, cancer onset and tumor progression. However, these events are usually defined by using computational techniques, whe...
Autores principales: | Korenjak, Michael, Zavadil, Jiri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890429/ https://www.ncbi.nlm.nih.gov/pubmed/31594033 http://dx.doi.org/10.1111/cas.14210 |
Ejemplares similares
-
Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans
por: Zhivagui, Maria, et al.
Publicado: (2019) -
Prioritizing cancer hazard assessments for IARC Monographs using an
integrated approach of database fusion and text mining
por: Barupal, Dinesh Kumar, et al.
Publicado: (2021) -
Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing
por: Huskova, H, et al.
Publicado: (2017) -
Chromatin Remodeler Smarca5 Is Required for Cancer-Related Processes of Primary Cell Fitness and Immortalization
por: Thakur, Shefali, et al.
Publicado: (2022) -
Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era
por: Porta‐Pardo, Eduard, et al.
Publicado: (2020)